whatshot

CTOR   $0.6897  -0.40% Market Open

Citius Oncology, Inc.
show_chart Advanced Chart of CTOR

Current temperature: 7.98
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 1
Target Price Mean 4.00
Mean unverified/preliminary 4.00 / 4.00
Target Price Low / High 4.00 / 4.00
Median / STD DEV 4.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell None Sell
rsi None Sell Sell
macd None None None
stoch ActivelyBuy None None
ma20 Sell Buy None
ma50 ActivelyBuy None None
ma100 Sell Buy None
Candlestick PatternJune 11, 2026 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US17331Y1091
ceo Mr. Leonard L. Mazur
Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York.Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.